These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20724948)

  • 1. Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
    Jain S; Gladwin MT
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e247-8. PubMed ID: 20724948
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
    Kaul DK; Zhang X; Dasgupta T; Fabry ME
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H39-47. PubMed ID: 18456737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
    Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse.
    Solovey A; Kollander R; Milbauer LC; Abdulla F; Chen Y; Kelm RJ; Hebbel RP
    Am J Hematol; 2010 Jan; 85(1):41-5. PubMed ID: 20029945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia.
    Sullivan KJ; Kissoon N; Gauger C
    Pediatr Crit Care Med; 2008 Mar; 9(2):159-68. PubMed ID: 18477929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell disease.
    McCarty MF
    Med Hypotheses; 2010 Jun; 74(6):1055-8. PubMed ID: 20089363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the most promising emerging therapies for sickle cell disease?
    Ferreira de Melo TR; Chin CM; dos Santos JL
    Future Med Chem; 2014 Jun; 6(9):979-82. PubMed ID: 25068981
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on arginine in sickle cell disease.
    Benites BD; Olalla-Saad ST
    Expert Rev Hematol; 2019 Apr; 12(4):235-244. PubMed ID: 30855194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new paradigm: calcium independent and caveolae internalization dependent release of nitric oxide by the endothelial nitric oxide synthase.
    Bkaily G; D'Orleans-Juste P; Jacques D
    Circ Res; 2006 Oct; 99(8):793-4. PubMed ID: 17038647
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
    Krajewski ML; Hsu LL; Gladwin MT
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H4-7. PubMed ID: 18502905
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease--mechanisms and consequences.
    Aslan M; Freeman BA
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):95-105. PubMed ID: 15040433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide production from hydroxyurea.
    King SB
    Free Radic Biol Med; 2004 Sep; 37(6):737-44. PubMed ID: 15304249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease.
    Bartolucci P; Ngo MT; Beuzard Y; Galactéros F; Saber G; Rideau D; Eddahibi S; Maitre B; Adnot S; Delclaux C
    Crit Care Med; 2007 Feb; 35(2):502-9. PubMed ID: 17167352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
    Jison ML; Gladwin MT
    Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
    Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF
    Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin II.
    Mulders AC; Hendriks-Balk MC; Mathy MJ; Michel MC; Alewijnse AE; Peters SL
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2043-8. PubMed ID: 16857953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.